The University of Ghana Medical School (UGMS) says its researchers have not developed any cassava-based compound that can reverse Type 2 diabetes.
This follows claims on social media that has gone viral, attributing such development to researchers of the nation’s premier university.
The University of Ghana Medical School said it strongly dissociates itself from the misinformation and is taking appropriate steps to address the matter.
A Monday, January 19, 2026 statement issued by the University clarified that it has not conducted any research leading to the development of such a compound referred to in the publication as “cassavarin”, adding that it has not isolated any substance by that name.
Also, the statement added that it has not undertaken any clinical trials related to the claims being peddled on social media, labeling reports of regulatory approvals, pharmaceutical lawsuits, and licensing arrangements as entirely fabricated.
The statement further urged the public to disregard the false publication, emphasising the UGMS’s highest standards of scientific integrity and ethical research practice.
In addition, the UGMS admonished the public to rely solely on information released through official University of Ghana channels for accurate and verified updates on research activities.
How to manage chronic illnesses and mental health at the workplace
